Kinesiophobia After Anterior Cruciate Ligament Reconstruction.
Launched by TARTU UNIVERSITY HOSPITAL · Feb 27, 2023
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how fear of movement, known as kinesiophobia, affects recovery after surgery for an anterior cruciate ligament (ACL) injury. After an ACL reconstruction, some patients may experience anxiety about moving their knee or returning to sports, which could slow down their recovery and increase the chance of getting hurt again. The study aims to understand these psychological factors better and how they relate to recovery.
To participate in the trial, you would need to be someone who had ACL reconstruction surgery at the Tartu University Hospital Sports Traumatology Centre between 2013 and 2019. Unfortunately, if you had a follow-up surgery on the same knee, had surgery on both knees at the same time, or had any infections after your surgery, you wouldn’t be eligible. If you join the study, you can expect to be part of research that aims to help improve recovery for future patients dealing with similar injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients underwent ACLR by three orthopaedic surgeons at the Tartu University Hospital Sports Traumatology Centre between 2013 and 2019.
- Exclusion Criteria:
- • Patients with revision ACLR, bilateral ACLR, and postoperative infections were excluded from the study.
About Tartu University Hospital
Tartu University Hospital is a leading academic medical center in Estonia, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a sponsor of clinical studies, the hospital leverages its extensive expertise in various medical fields, fostering collaboration between researchers, healthcare professionals, and patients. With a focus on improving patient outcomes and contributing to the global medical community, Tartu University Hospital is dedicated to conducting rigorous and ethically sound clinical research that addresses critical health challenges. Its state-of-the-art facilities and multidisciplinary approach enable the exploration of new therapies and treatment modalities, positioning it at the forefront of medical advancement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tartu, Tartumaa, Estonia
Patients applied
Trial Officials
Leho Rips, MD
Principal Investigator
Tartu University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials